Patient recruitment, retention, diversity, safety, and data collection & analysis are all factors driving the need for radical innovation in clinical drug development. This need has been made painfully apparent during the current COVID-19 pandemic. With clinical research quickly adapting, Sponsors, Sites & CROs can adopt new methods to digitally transform their protocols for improved scientific outcomes.
With 77% of surveyed pharmaceutical executives planning to run a hybrid or decentralized trial this year, it’s important to understand the benefits of web-enabled research tools and how they work.
With this free white paper you’ll:
- Gain an overview of decentralized trials
- Understand the core components of hybrid/remote trials
- Discover why these patient-centric trials are the future of research